Eli Lilly Norge AS is a subsidiary of the American pharmaceutical company Eli Lilly and Company, which was founded in 1876. The company is known for its research and development of innovative medicines in several therapeutic areas, including diabetes, oncology, immunology and neuroscience. Eli Lilly has a significant presence in the Norwegian market and contributes to the healthcare system through its products and services.
The company focuses on improving patients' quality of life by offering effective treatment options. Eli Lilly Norge AS actively participates in clinical research and collaborates with healthcare personnel to develop new treatment methods. In addition, they are involved in various community initiatives aimed at promoting health and well-being.